Viking Therapeutics, Inc. (VKTX) Form 10-K Annual Reports
Viking Therapeutics, Inc. (VKTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VKTX
CIK: 1607678
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerSteve Rapattoni
Audit LocationCosta Mesa, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-28 | 2026-09-23 | 8-K | 0001193125-26-405580 | View SEC Doc Filr Page |
| 424B5 | 2026-09-25 | — | 424B5 | 0001193125-26-401385 | View SEC Doc Filr Page |
| 424B5 | 2026-09-25 | — | 424B5 | 0001193125-26-401384 | View SEC Doc Filr Page |
| FWP | 2026-09-24 | — | FREE WRITING PROSPECTUS | 0001213900-26-102798 | View SEC Doc Filr Page |
| 305B2 | 2026-09-24 | — | APPLICATION FOR DESIGNATION OF A NEW TRUSTEE | 0001213900-26-102782 | View SEC Doc Filr Page |
| 424B5 | 2026-09-23 | — | 424B5 | 0001193125-26-399628 | View SEC Doc Filr Page |
| 424B5 | 2026-09-23 | — | 424B5 | 0001193125-26-399627 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | 8-K | 0001193125-26-397219 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-01 | 4 | 0002144542-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-08-07 | 2026-08-01 | 3 | 0002144542-26-000003 | View SEC Doc Filr Page |
| S-3ASR | 2026-07-30 | — | S-3ASR | 0001193125-26-324455 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | 4 | 0001193125-26-324448 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | 4 | 0001193125-26-324447 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-28 | 4 | 0001193125-26-324446 | View SEC Doc Filr Page |
| 10-Q | 2026-07-29 | 2026-06-30 | 10-Q | 0001193125-26-324219 | View SEC Doc Filr Page |
| 144 | 2026-07-29 | — | 144 Filing | 0001950047-26-007394 | View SEC Doc Filr Page |
| 8-K | 2026-07-29 | 2026-07-29 | 8-K | 0001193125-26-323652 | View SEC Doc Filr Page |
| 144 | 2026-07-29 | — | 144 Filing | 0001950047-26-007380 | View SEC Doc Filr Page |
| 144 | 2026-07-29 | — | 144 Filing | 0001950047-26-007376 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 | 0001193125-26-256039 | View SEC Doc Filr Page |
| 3 | 2026-06-03 | 2026-06-01 | 3 | 0001193125-26-256038 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-19 | 8-K | 0001193125-26-239535 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-30 | — | SCHEDULE 13G Filing | 0002100119-26-001179 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0001193125-26-193315 | View SEC Doc Filr Page |
| 8-K | 2026-04-29 | 2026-04-29 | 8-K | 0001193125-26-191487 | View SEC Doc Filr Page |